Sam Iki has extensive experience in program and project management within the biopharmaceutical industry, currently serving as Senior Vice President of Program Management at Vaxcyte since July 2017. Prior roles include Vice President of Project Management at NGM Biopharmaceuticals from August 2015 to July 2017, and Vice President of Project Management at XenoPort, Inc. from January 2005 to July 2015. Additional experience includes positions as Project Manager at Tularik and Manager of Project Management at DrugAbuse Sciences, Inc. Sam Iki began the career as an Associate Scientist in Medical Research at Miravant Medical Technologies. Academically, Sam Iki holds a Master of Science degree from Georgetown University and a Bachelor's degree from Occidental College.
This person is not in any offices
Vaxcyte
2 followers
Vaxcyte, formerly known as SutroVax, is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.